Acquired pure red cell aplasia associated with malignant lymphomas: A nationwide cohort study in Japan for the PRCA Collaborative Study Group

American Journal of Hematology

Volumn 84, Issue 3, 2009, Pages 144-148

  Hirokawa, Makoto ^a   Sawada, Ken Ichi ^a   Fujishima, Naohito ^a   Kawano, Fumio ^b   Kimura, Akiro ^c   Watanabe, Takashi ^d   Arai, Ayako ^e   Matsui, Toshimitsu ^f   Nakao, Shinji ^g   Urabe, Akio ^h   Omine, Mitsuhiro ⁱ   Ozawa, Keiya ^j  

^a AKITA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g KANAZAWA UNIVERSITY   (Japan)

^h Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

ⁱ SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^j JICHI MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; LYMPHOMA; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PURE RED CELL ANEMIA; REMISSION;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; LYMPHOMA; MALE; MIDDLE AGED; RED-CELL APLASIA, PURE;

EID: 62949225621     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21354     Document Type: Article

References (38)

1. Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J NCI 2006;98:51-60.
2. Smedby KE, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: A pooled analysis within the InterLymph Consortium. Blood 2008;111:4029-4038.
3. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphopro-liferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996;14:1943-1949.
4. Dessypris EN. Pure Red Cell Aplasia. Baltimore, London: The Johns Hopkins University Press; 1988. pp 41-113.
5. Kuramoto K, Oda K, Katsutani S, et al. Acquired pure red cell aplasia associated with relapsed non-Hodgkin's lymphoma: A case report-improvement of PRCA after acute hepatitis. Rinsho Ketsueki 1998;39:290-296.
6. Boldt DH, Kopecky KJ, Head D, et al. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience. Leukemia 1994;8:2118-2126.
7. Morgan E, Pang KM, Goldwasser E. Hodgkin disease and red cell aplasia. Am J Hematol 1978;5:71-75.
8. Natori Y, Yamagishi A, Maeda S. Hodgkin's disease associated with pure red cell aplasia-report of a case. Rinsho Ketsueki 1986;27:219-224.
9. Hirosawa S, Kamiyama R, Dan K, Kuriya S, Nomura T. A case malignant lym-phoma associated with pure red cell aplasia. Rinsho Ketsueki 1982;23:1463-1467.
10. Vukelja SJ, Krishnan J, Link CM, et al. Resolution of pure red cell aplasia and lymphoma: Response to intravenous gammaglobulin and combination chemotherapy. Am J Hematol 1989;32:129-133.
11. Tsujimura H, Sakai C, Takagi T. Pure red cell aplasia complicated by angio-immunoblastic T-cell lymphoma: Humoral factor plays a main role in the inhibition of erythropoiesis from CD34(+) progenitor cells. Am J Hematol 1999;62:259-260.
12. Katayama H, Takeuchi M, Yoshino T, et al. Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia. Leuk Lymphoma 2001;42:539-542.
13. Nakashima Y, Abe Y, Ohtsuka R, et al. Follicular lymphoma complicated with autoimmune hemolytic anemia and pure red cell aplasia. Rinsho Ketsueki 2004;45:1208-1210.
14. Mizobe T, Tsukada J, Higashi T, et al. Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia. Rinsho Ketsueki 2005;46:211-216.
15. Kuroda H, Matsunaga T, Iyama S, et al. De novo CD5-positive diffuse large B-cell lymphoma associated with autoimmune hemolytic anemia presenting as erythroid hypoplasia. Rinsho Ketsueki 2006;47:633-638.
16. Narra K, Borghaei H, Al-Saleem T, et al. Pure red cell aplasia in B-cell lym-phoproliferative disorder treated with rituximab: Report of two cases and review of the literature. Leuk Res 2006;30:109-114.
17. Suzuki T, Kumagai T, Kitano A, et al. Pure red cell aplasia successfully treated with rituximab in a patient with relapsed diffuse large B-cell lym-phoma. Rinsho Ketsueki 2007;48:67-70.
18. Sumi M, Ichikawa N, Shimizu I, et al. Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and ery-throid hypoplasia. Rinsho Ketsueki 2007;48:571-575.
19. Reid TJ III, Mullaney M, Burrell LM, et al. Pure red cell aplasia after chemo therapy for Hodgkin's lymphoma: In vitro evidence for T cell mediated suppression of erythropoiesis and response to sequential cyclosporin and erythropoietin. Am J Hematol 1994;46:48-53.
20. Mohri H, Harano H, Okubo T. Concomitant association of myasthenia gravis and pure red cell aplasia after chemotherapy for Hodgkin's disease. Am J Hematol 1997;54:343.
21. Alter R, Joshi SS, Verdirame JD, Weisenburger DD. Pure red cell aplasia associated with B cell lymphoma: Demonstration of bone marrow colony inhi bition by serum immunoglobulin. Leuk Res 1990;14:279-286.
22. Martelli M, Ponchio L, Beguin Y, et al. Pure red cell aplasia following peripheral stem cell transplantation: Complete response to a short course of high-dose recombinant human erythropoietin. Haematologica 1994;79:456-459.
23. Sharma VR, Fleming DR, Slone SP. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood 2000;96:1184-1186.
24. Toyota S, Nakamura N, Dan K. Coexistence of pure red cell aplasia and autoimmune hemolytic anemia occurring during remission of malignant lymphoma. Rinsho Ketsueki 2002;43:493-495.
25. Song KW, Mollee P, Patterson B, et al. Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma. Br J Haematol 2002;119:125-127.
26. Herbert KE, Prince HM, Westerman DA. Pure red-cell aplasia due to parvovirus B19 infection in a patient treated with alemtuzumab. Blood 2003;101:1654.
27. Isobe Y, Sugimoto K, Shiraki Y, et al. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy. Am J Hematol 2004;77:370-373.
28. Sawada K, Hirokawa M, Fujishima N, et al. Long-term relapse-free survival and overall survival of patients with acquired primary idiopathic PRCA receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica 2007;92:1021-1028.
29. Wohrer S, Troch M, Zwerina J, et al. Influence of rituximab, cyclophospha-mide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases. Ann Oncol 2007;18:647-651.
30. Clark AD, Dessypris EN, Krantz SB. Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 1984;63:277-286.
31. Hirokawa M, Sawada K, Fujishima N, et al. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica 2008;93:27-33.
32. Fujishima N, Sawada K, Hirokawa M, et al. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: A Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group. Haematologica 2008;93:1555-1559.
33. Sawada K, Fujishima N, Hirokawa M. Acquired pure red cell aplasia: Updated review of treatment. Br J Haematol 2008;142:505-514.
34. Hauswirth AW, Skrabs C, Schützinger C, et al. Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lympho-mas. Leuk Lymphoma 2007;48:1139-1149.
35. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia in AIDS. Ann Intern Med 1990;113:926-933.
36. Ahsan N, Holman MJ, Gocke CD, et al. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation. Clin Transpl 1997;11:265-270.
37. Wong TY, Chan PK, Leung CB, et al. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 1999;34:1132-1136.
38. Diehl LF, Ketchum LH. Autoimmune disease and chronic lymphocytic leukemia: Autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 1998;25:80-97.